Position in ABUS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,124,000
+$132,750 QoQ
Shares Held
442,500
0.0% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#37
of 175 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Freestone Capital Holdings, LLC holds $7,262,289 across 14 Biotechnology names. ABUS ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
This page
|
442,500 | $2,124,000 | |
| 2 | IMNM |
Immunome Inc.
|
60,589 | $1,283,880 | |
| 3 | BNTX |
BioNTech SE
|
7,914 | $736,397 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
904 | $563,680 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,004 | $498,716 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,700 | $410,811 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,109 | $394,973 | |
| 8 | EXEL |
Exelixis, Inc.
|
6,974 | $379,455 |
All Filings in ABUS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,124,000 | 442,500 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,991,250 | 442,500 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,128,425 | 442,500 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $2,008,950 | 442,500 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,367,325 | 442,500 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,544,325 | 442,500 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,446,975 | 442,500 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $1,706,320 | 443,200 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,687,918 | 546,252 | Shares | Defined | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||